Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) reached a new 52-week low during mid-day trading on Friday. The stock traded as low as GBX 0.48 and last traded at GBX 0.50, with a volume of 6,968 shares traded. The stock had previously closed at GBX 0.49.
Integrated Diagnostics Price Performance
The firm has a market capitalization of £2.91 million, a P/E ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.44. The company has a quick ratio of 0.75, a current ratio of 1.67 and a debt-to-equity ratio of 42.91. The business’s 50 day moving average is GBX 0.53 and its 200-day moving average is GBX 0.55.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
Read More
- Five stocks we like better than Integrated Diagnostics
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
